- Home
- PCRX
as 12-20-2024 4:00pm EST
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | TAMPA |
| Market Cap: | 604.7M | IPO Year: | 2011 |
| Target Price: | $26.60 | AVG Volume (30 days): | 924.6K |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.96 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.16 - $35.95 | Next Earning Date: | 11-06-2024 |
| Revenue: | $694,957,000 | Revenue Growth: | 4.40% |
| Revenue Growth (this year): | 4.92% | Revenue Growth (next year): | -2.18% |
Latest Pacira BioSciences Inc. News
PCRX Breaking Stock News: Dive into PCRX Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
Here's Why Pacira (PCRX) is a Strong Momentum Stock
Argus Research
5 days ago
PCRX: What does Argus have to say about PCRX?
PR Newswire
11 days ago
DOMA Perpetual Capital Management Announces Intent to Nominate Four Highly Qualified, Independent Director Candidates at 2025 Annual Meeting of Pacira BioSciences, Inc.
Argus Research
12 days ago
PCRX: Raising target price to $16.00
GlobeNewswire
16 days ago
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Argus Research
19 days ago
PCRX: What does Argus have to say about PCRX?
GlobeNewswire
19 days ago
Pacira Awarded New U.S. Patent Covering EXPAREL Composition
Zacks
23 days ago
Why Pacira (PCRX) is a Top Momentum Stock for the Long-Term
Compare PCRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PCRX Pacira BioSciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.